• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在微创外科手术和术中甲状旁腺激素监测时代,228例患者接受再次甲状旁腺切除术。

Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring.

作者信息

Richards Melanie L, Thompson Geoff B, Farley David R, Grant Clive S

机构信息

Mayo Clinic, Department of Surgery, Rochester, MN, USA.

出版信息

Am J Surg. 2008 Dec;196(6):937-42; discussion 942-3. doi: 10.1016/j.amjsurg.2008.07.022.

DOI:10.1016/j.amjsurg.2008.07.022
PMID:19095113
Abstract

BACKGROUND

Reoperative parathyroidectomy (R-PTX) in primary hyperparathyroidism (1HPT) has increased failure rates and morbidity. This study evaluated R-PTX during the era of minimal-access PTX with intraoperative parathyroid hormone (IOPTH) monitoring.

METHODS

Two thousand sixty-five patients with 1HPT who underwent PTX were assessed for R-PTX. Preoperative studies, operative findings, and outcomes were evaluated.

RESULTS

Two hundred twenty-eight patients underwent 236 R-PTX procedures. Imaging performed included sestamibi (89%), ultrasound (US; 56%), computed axial tomography/magnetic resonance imaging (5%), and selective venous sampling (1%). Sestamibi was more sensitive than US (84% vs 68%). Curative surgery was performed in 89% of patients. IOPTH was 99% sensitive. There was no relationship between cure and the following parameters: preoperative calcium or PTH levels, persistent or recurrent disease, or use of IOPTH. Solitary gland disease and a single previous operation were associated with increased likelihood of cure (P = .06). Hypoparathyroidism was decreased using IOPTH monitoring (2% vs 9%). One patient had recurrent laryngeal nerve palsy.

CONCLUSIONS

R-PTX can be performed effectively with minimal complications. IOPTH is an accurate predictor of cure and may decrease the frequency of permanent hypoparathyroidism.

摘要

背景

原发性甲状旁腺功能亢进症(1HPT)再次手术甲状旁腺切除术(R-PTX)的失败率和发病率有所增加。本研究评估了在微创甲状旁腺切除术时代并采用术中甲状旁腺激素(IOPTH)监测的R-PTX。

方法

对2065例行甲状旁腺切除术的1HPT患者进行R-PTX评估。对术前检查、手术发现和结果进行评估。

结果

228例患者接受了236次R-PTX手术。所进行的影像学检查包括锝[99mTc]甲氧基异丁基异腈(89%)、超声(US;56%)、计算机断层扫描/磁共振成像(5%)和选择性静脉采血(1%)。锝[99mTc]甲氧基异丁基异腈比超声更敏感(84%对68%)。89%的患者接受了根治性手术。IOPTH的敏感性为99%。治愈与以下参数之间无相关性:术前血钙或甲状旁腺激素水平、持续性或复发性疾病或IOPTH的使用。孤立性腺疾病和既往单次手术与治愈可能性增加相关(P = 0.06)。使用IOPTH监测可降低甲状旁腺功能减退症的发生率(2%对9%)。1例患者发生喉返神经麻痹。

结论

R-PTX可有效进行,并发症极少。IOPTH是治愈的准确预测指标,可能会降低永久性甲状旁腺功能减退症的发生率。

相似文献

1
Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring.在微创外科手术和术中甲状旁腺激素监测时代,228例患者接受再次甲状旁腺切除术。
Am J Surg. 2008 Dec;196(6):937-42; discussion 942-3. doi: 10.1016/j.amjsurg.2008.07.022.
2
Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.术中甲状旁腺激素测定主要改善了术前影像学检查未发现一致性且疑似孤立性甲状旁腺腺瘤患者的微创甲状旁腺切除术的治疗效果。
Clin Endocrinol (Oxf). 2007 Jun;66(6):878-85. doi: 10.1111/j.1365-2265.2007.02827.x. Epub 2007 Apr 15.
3
Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach.再次甲状旁腺切除术:一种用于术中甲状旁腺激素水平成像和监测的算法,可实现成功的精准手术方法。
Surgery. 2008 Oct;144(4):611-9; discussion 619-21. doi: 10.1016/j.surg.2008.06.017.
4
Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.多腺体疾病引起原发性甲状旁腺功能亢进症术中甲状旁腺激素检测的应用。
Ann Surg Oncol. 2009 Dec;16(12):3450-4. doi: 10.1245/s10434-009-0699-7. Epub 2009 Sep 4.
5
Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.甲状旁腺切除术后最终术中甲状旁腺激素水平与预后的关系。
Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1103-7. doi: 10.1001/archoto.2009.155.
6
Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进患者行微创甲状旁腺切除术且术中未进行甲状旁腺激素监测
Br J Surg. 2007 Jan;94(1):42-7. doi: 10.1002/bjs.5574.
7
Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies.微创甲状旁腺切除术:在两项术前定位研究后使用术中甲状旁腺激素检测
Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1108-11. doi: 10.1001/archoto.2009.160.
8
Parathyroidectomy outcomes according to operative approach.根据手术方式的甲状旁腺切除术结果
Am J Surg. 2007 Mar;193(3):368-72; discussion 372-3. doi: 10.1016/j.amjsurg.2006.09.023.
9
The additional value of intraoperative parathyroid hormone assessment is marginal in patients with nonfamilial primary hyperparathyroidism: a prospective cohort study.在非家族性原发性甲状旁腺功能亢进症患者中,术中甲状旁腺激素评估的附加价值是微不足道的:一项前瞻性队列研究。
Am J Surg. 2012 Jul;204(1):1-6. doi: 10.1016/j.amjsurg.2011.07.017. Epub 2011 Dec 21.
10
Targeted parathyroidectomy: effectiveness and intraoperative rapid-parathormone dynamics.靶向甲状旁腺切除术:有效性及术中甲状旁腺素快速动态变化
Laryngoscope. 2008 Nov;118(11):1997-2002. doi: 10.1097/MLG.0b013e3181817b77.

引用本文的文献

1
Intraoperative Parathyroid Hormone Monitoring Criteria in Primary Hyperparathyroidism: A Network Meta-Analysis of Diagnostic Test Accuracy.原发性甲状旁腺功能亢进症术中甲状旁腺激素监测标准:诊断试验准确性的网状Meta分析
JAMA Otolaryngol Head Neck Surg. 2025 Mar 1;151(3):190-200. doi: 10.1001/jamaoto.2024.4453.
2
Post-surgical Persistent Hyperparathyroidism Successfully Treated with Parathyroid Radiofrequency Ablation: A Case Report.甲状旁腺射频消融术成功治疗术后持续性甲状旁腺功能亢进:一例报告
Endocr Metab Immune Disord Drug Targets. 2025;25(1):80-84. doi: 10.2174/0118715303308277240419062634.
3
A case of mediastinal hyperparathyromatosis.
一例纵隔甲状旁腺增生症。
J Surg Case Rep. 2024 Jan 18;2024(1):rjad735. doi: 10.1093/jscr/rjad735. eCollection 2024 Jan.
4
Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.多发性内分泌腺瘤病 1 型综合征中的复发性原发性甲状旁腺功能亢进症。
Physiol Res. 2023 Dec 17;72(S4):S423-S427. doi: 10.33549/physiolres.935223.
5
Persistent and Recurrent Primary Hyperparathyroidism: Intraoperative Supplemental Methods, Basic Principles of Surgery, and Other Treatment Options.持续性和复发性原发性甲状旁腺功能亢进症:术中补充方法、手术基本原则及其他治疗选择
Sisli Etfal Hastan Tip Bul. 2023 Jun 20;57(2):143-152. doi: 10.14744/SEMB.2023.47701. eCollection 2023.
6
Persistent and Recurrent Primary Hyperparathyroidism: Etiological Factors and Pre-Operative Evaluation.持续性和复发性原发性甲状旁腺功能亢进:病因学因素及术前评估
Sisli Etfal Hastan Tip Bul. 2023 Mar 21;57(1):1-17. doi: 10.14744/SEMB.2023.39260. eCollection 2023.
7
Management of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症的管理
Indian J Surg Oncol. 2022 Mar;13(1):143-151. doi: 10.1007/s13193-021-01319-3. Epub 2021 Apr 27.
8
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.《欧洲专家共识:成人和妊娠甲状旁腺疾病特定方面的实用管理:甲状旁腺疾病 ESE 教育计划的建议》。
Eur J Endocrinol. 2022 Jan 13;186(2):R33-R63. doi: 10.1530/EJE-21-1044. Print 2022 Feb 1.
9
Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery.甲状旁腺腺瘤定位在原发性甲状旁腺功能亢进症重复手术患者中的诊断效果评估。
Langenbecks Arch Surg. 2021 Aug;406(5):1615-1624. doi: 10.1007/s00423-021-02191-z. Epub 2021 May 16.
10
What to do when the parathyroid gland is not found during a transcervical exploration?经颈部探查未能发现甲状旁腺时该如何处理?
Interact Cardiovasc Thorac Surg. 2021 Jun 28;33(1):82-84. doi: 10.1093/icvts/ivab043.